Cargando…

Validity and Reliability of CAT and Dyspnea-12 in Bronchiectasis and Tuberculous Destroyed Lung

BACKGROUND: The objective of this study was to assess the validity and reliability of the Korean version of chronic obstructive pulmonary disease assessment test (CAT) and Dyspnea-12 Questionnaire for patients with bronchiectasis or tuberculous destroyed lung. METHODS: For 62 bronchiectasis patients...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Bo Young, Lee, Seohyun, Lee, Jae Seung, Song, Jin Woo, Lee, Sang-Do, Jang, Seung Hun, Jung, Ki-Suck, Hwang, Yong Il, Oh, Yeon-Mok
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Academy of Tuberculosis and Respiratory Diseases 2012
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3475455/ https://www.ncbi.nlm.nih.gov/pubmed/23101012 http://dx.doi.org/10.4046/trd.2012.72.6.467

Ejemplares similares

Predicting Mortality in Patients with Tuberculous Destroyed Lung Receiving Mechanical Ventilation
por: Kim, Won-Young, et al.
Publicado: (2018)

Epithelial to Mesenchymal Transition of Mesothelial Cells in Tuberculous Pleurisy
por: Kim, Changhwan, et al.
Publicado: (2011)

Effects of inhaler therapy on mortality in patients with tuberculous destroyed lung and airflow limitation
por: Kim, Ho Cheol, et al.
Publicado: (2019)

Efficacy of Inhaled Iloprost in Cor Pulmonale and Severe Pulmonary Hypertension Associated with Tuberculous Destroyed Lung
por: Park, Yae Min, et al.
Publicado: (2014)

Routine Pulmonary Function Test Can Estimate the Extent of Tuberculous Destroyed Lung
por: Lee, Eun Joo, et al.
Publicado: (2012)

Validation of the Korean Version of the Bronchiectasis Health Questionnaire
por: Kim, Hyun Kuk, et al.
Publicado: (2020)

Effects of treatment with long-acting muscarinic antagonists (LAMA) and long-acting beta-agonists (LABA) on lung function improvement in patients with bronchiectasis: an observational study
por: Lee, Su Yeon, et al.
Publicado: (2021)

Prevalence of asymptomatic bronchiectasis and associations among the health screening population in South Korea
por: Kim, Soo Han, et al.
Publicado: (2021)

Increased Incidence and Associated Risk Factors of Aspergillosis in Patients with Bronchiectasis
por: Yang, Bumhee, et al.
Publicado: (2021)

Clinical Impact of the Bronchiectasis with Chronic Bronchitis Symptoms in COPD: Analysis of a Longitudinal Cohort
por: Kim, Eun Kyung, et al.
Publicado: (2021)

Clinical Characteristics of Patients with Post-Tuberculosis Bronchiectasis: Findings from the KMBARC Registry
por: Choi, Hayoung, et al.
Publicado: (2021)

Survey of the management of patients with bronchiectasis: a pilot investigation in Asian populations
por: Kim, Ho Cheol, et al.
Publicado: (2021)

Characterizing Non-Tuberculous Mycobacteria Infection in Bronchiectasis
por: Faverio, Paola, et al.
Publicado: (2016)

Effect of Inhaled Tiotropium on Spirometric Parameters in Patients with Tuberculous Destroyed Lung
por: Yum, Ho-Kee, et al.
Publicado: (2014)

Discrepancies between modified Medical Research Council dyspnea score and COPD assessment test score in patients with COPD
por: Rhee, Chin Kook, et al.
Publicado: (2015)

Chronic Obstructive Pulmonary Disease Is Associated With Decreased Quality of Life in Bronchiectasis Patients: Findings From the KMBARC Registry
por: Kim, Sang Hyuk, et al.
Publicado: (2021)

Characterization of the severity of dyspnea in patients with bronchiectasis: correlation with clinical, functional, and tomographic aspects
por: de Nucci, Maria Cecília Nieves Maiorano, et al.
Publicado: (2020)

Effect of tiotropium inhaler use on mortality in patients with tuberculous destroyed lung: based on linkage between hospital and nationwide health insurance claims data in South Korea
por: Kim, Ho Cheol, et al.
Publicado: (2019)

Two Cases of Bronchiectasis (Non-Tuberculous) Treated with Autogenous Vaccines
por: Fleming, Robert A., et al.
Publicado: (1915)

Body habitus in patients with and without bronchiectasis and non-tuberculous mycobacteria
por: Schweitzer, Michael D., et al.
Publicado: (2017)

Dyspnea and Palpitation during Pregnancy
por: Choi, Hyun Suk, et al.
Publicado: (2001)

Characterization of Microbiota in Bronchiectasis Patients with Different Disease Severities
por: Lee, Sang Hoon, et al.
Publicado: (2018)

A Validation Study for the Korean Version of Chronic Obstructive Pulmonary Disease Assessment Test (CAT)
por: Hwang, Yong Il, et al.
Publicado: (2013)

Destroy, what destroys you
por: Luu, Khang, et al.
Publicado: (2019)

Developing a Diagnostic Bundle for Bronchiectasis in South Korea: A Modified Delphi Consensus Study
por: Choi, Hayoung, et al.
Publicado: (2022)

Inhaled indacaterol for the treatment of COPD patients with destroyed lung by tuberculosis and moderate-to-severe airflow limitation: results from the randomized INFINITY study
por: Kim, Cheong-Ju, et al.
Publicado: (2017)

Morphological features of bronchiectasis in patients with non-tuberculous mycobacteriosis and interstitial pneumonia
por: Tabe, Chiori, et al.
Publicado: (2022)

Effectiveness of the use of an oscillating positive expiratory pressure device in bronchiectasis with frequent exacerbations: a single-arm pilot study
por: Kim, So Rae, et al.
Publicado: (2023)

Respiratory Viruses in Acute Exacerbations of Bronchiectasis
por: Park, Yea Eun, et al.
Publicado: (2021)

Factors Associated with Indacaterol Response in Tuberculosis-Destroyed Lung with Airflow Limitation
por: Kim, Tae Hoon, et al.
Publicado: (2019)

The Reliability of the Arabic Version of the Dyspnea Index Questionnaire for Upper Airway-Related Dyspnea
por: Alrabiah, Abdulaziz, et al.
Publicado: (2022)

Gastro-oesophageal reflux disease increases healthcare use and medical costs in patients with bronchiectasis: a Korean nationwide population-based study
por: Yoon, Jai Hoon, et al.
Publicado: (2021)

Respiratory symptoms and health-related quality of life in post-tuberculosis subjects with physician-diagnosed bronchiectasis: a cross-sectional study
por: Kim, Taehee, et al.
Publicado: (2021)

Hemoptysis as the presenting manifestation of bronchiectasis-associated hospitalization in Korea
por: Seo, Hyewon, et al.
Publicado: (2023)

Rivaroxaban versus Low-Molecular-Weight Heparin for Venous Thromboembolism in Gastrointestinal and Pancreatobiliary Cancer
por: Lee, Jang Ho, et al.
Publicado: (2019)

Prevalence of chronic rhinosinusitis and its relating factors in patients with bronchiectasis: findings from KMBARC registry
por: Yu, Iseul, et al.
Publicado: (2022)

KMBARC registry: protocol for a multicentre observational cohort study on non-cystic fibrosis bronchiectasis in Korea
por: Lee, Hyun, et al.
Publicado: (2020)

Characterisation of the post-tuberculous phenotype of bronchiectasis: A real-world observational study
por: Fong, Isaac, et al.
Publicado: (2022)

Association of low fat mass with nontuberculous mycobacterial infection in patients with bronchiectasis
por: Lim, Sung Yoon, et al.
Publicado: (2021)

Impacts of Asthma in Patients With Bronchiectasis: Findings From the KMBARC Registry
por: Moon, Seong Mi, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_s15aqiufegposof3ncq69kiof0